To demonstrate the presence of disulfide-linked tau oligomers in the patient’s brain, we analyzed human brain lysates of AD and age-matched controls (Non-AD) obtained from the Boston University Alzheimer’s Disease Research Center (BUADRC) (Supplementary Fig. 4). Here, MAPT is linked to glycogen storage disease VI.